ImmuCell Corporation
About ImmuCell Corporation
ImmuCell Corporation (NASDAQ: ICCC) is an animal health biotechnology company developing products that improve the health and productivity of dairy and beef cattle. The company's flagship product, First Defense, is an orally delivered scours prevention treatment for newborn calves that protects against E. coli, coronavirus, and rotavirus using proprietary colostrum hyper-immunization technology. ImmuCell also produces the California Mastitis Test for on-farm somatic cell detection. The company operates a USDA-licensed manufacturing facility in Portland, Maine.
Company Details
- Headquarters:
- Portland, Maine
- Founded:
- 1982
- Website:
- https://immucell.com
Product Categories
ImmuCell Corporation operates across multiple segments of the dairy industry, providing solutions in the following areas:
- Calf Health
- Scours Prevention
- Mastitis Testing
- Animal Biologicals